[1]
I. Hameed, O. M. Siddiqui, and S. A. Samad, “MAVACAMTEN: A door that has opened in the treatment of Hyper-trophic Cardiomyopathy”, J Pak Med Assoc, vol. 73, no. 2, pp. 446–447, Feb. 2023.